North America Hematology Analyzers and Reagents Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Hematology Analyzers and Reagents Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Hematology Analyzers and Reagents Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Hematology Analyzers and Reagents Market Regional Analysis

6.2 North America Hematology Analyzers and Reagents Market Revenue 2017-2027 (US$ Million)

6.3 North America Hematology Analyzers and Reagents Market Forecast Analysis

7. North America Hematology Analyzers and Reagents Market Analysis – by Product and Service

7.1 Hematology Products and Services

7.1.1 Overview
7.1.2 Hematology Products and Services: North America Hematology Analyzers and Reagents Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.2 Hemostasis Products and Services

7.2.1 Overview
7.2.2 Hemostasis Products and Services: North America Hematology Analyzers and Reagents Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.3 Immunohematology Products and Services

7.3.1 Overview
7.3.2 Immunohematology Products and Services: North America Hematology Analyzers and Reagents Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. North America Hematology Analyzers and Reagents Market Analysis – by Application

8.1 Anemia

8.1.1 Overview
8.1.2 Anemia: North America Hematology Analyzers and Reagents Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.2 Blood Cancer

8.2.1 Overview
8.2.2 Blood Cancer: North America Hematology Analyzers and Reagents Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.3 Hemorrhagic Conditions

8.3.1 Overview
8.3.2 Hemorrhagic Conditions: North America Hematology Analyzers and Reagents Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.4 Infection Related Conditions

8.4.1 Overview
8.4.2 Infection Related Conditions: North America Hematology Analyzers and Reagents Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.5 Immune System Related Conditions

8.5.1 Overview
8.5.2 Immune System Related Conditions: North America Hematology Analyzers and Reagents Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. North America Hematology Analyzers and Reagents Market Analysis – by End User

9.1 Hospital Laboratories

9.1.1 Overview
9.1.2 Hospital Laboratories: North America Hematology Analyzers and Reagents Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.2 Commercial Service Providers

9.2.1 Overview
9.2.2 Commercial Service Providers: North America Hematology Analyzers and Reagents Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.3 Government Reference Laboratories

9.3.1 Overview
9.3.2 Government Reference Laboratories: North America Hematology Analyzers and Reagents Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.4 Research and Academic Institutes

9.4.1 Overview
9.4.2 Research and Academic Institutes: North America Hematology Analyzers and Reagents Market – Revenue and Forecast, 2017-2027 (US$ Million)

10. North America Hematology Analyzers and Reagents Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Hematology Analyzers and Reagents Market Breakdown, by Key Country, 2020 and 2027 (%)
10.2.1.1 North America Hematology Analyzers and Reagents Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Hematology Analyzers and Reagents Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.1.1 US: North America Hematology Analyzers and Reagents Market Breakdown, by Product and Service
10.2.1.1.2 US: North America Hematology Analyzers and Reagents Market Breakdown, by Application
10.2.1.1.3 US: North America Hematology Analyzers and Reagents Market Breakdown, by End User

10.2.1.2 Canada: North America Hematology Analyzers and Reagents Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.2.1 Canada: North America Hematology Analyzers and Reagents Market Breakdown, by Product and Service
10.2.1.2.2 Canada: North America Hematology Analyzers and Reagents Market Breakdown, by Application
10.2.1.2.3 Canada: North America Hematology Analyzers and Reagents Market Breakdown, by End User

10.2.1.3 Mexico : North America Hematology Analyzers and Reagents Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.3.1 Mexico : North America Hematology Analyzers and Reagents Market Breakdown, by Product and Service
10.2.1.3.2 Mexico : North America Hematology Analyzers and Reagents Market Breakdown, by Application
10.2.1.3.3 Mexico : North America Hematology Analyzers and Reagents Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Clinical Diagnostic Solutions, Inc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Danaher

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 BIO-RAD LABORATORIES INC.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Abbott

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 ERBA Diagnostics Inc.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 EKF Diagnostics

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 HORIBA Medical

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Hematology Analyzers and Reagents Market